ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Kane Biotech Inc (QB)

Kane Biotech Inc (QB) (KNBIF)

0.08
0.0025
(3.23%)
Cerrado 11 Diciembre 3:00PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.08
Postura de Compra
0.0707
Postura de Venta
100.08
Volume Operado de la Acción
305,000
0.0768 Rango del Día 0.08
0.044 Rango de 52 semanas 0.12277
Capitalización de Mercado [m]
Precio Anterior
0.0775
Precio de Apertura
0.0768
Última hora de negociación
Volumen financiero
US$ 23,894
Precio Promedio Ponderado
0.078341
Volumen promedio (3 m)
17,395
Acciones en circulación
131,844,567
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.75
Beneficio por acción (BPA)
-0.04
turnover
2.82M
Beneficio neto
-5.27M

Acerca de Kane Biotech Inc (QB)

Sector
Coml Physical, Biologcl Resh
Industria
Coml Physical, Biologcl Resh
Sede
Winnipeg, Manitoba, Can
Fundado
-
Kane Biotech Inc (QB) is listed in the Coml Physical, Biologcl Resh sector of the OTCMarkets with ticker KNBIF. The last closing price for Kane Biotech (QB) was US$0.08. Over the last year, Kane Biotech (QB) shares have traded in a share price range of US$ 0.044 to US$ 0.12277.

Kane Biotech (QB) currently has 131,844,567 shares in issue. The market capitalisation of Kane Biotech (QB) is US$10.22 million. Kane Biotech (QB) has a price to earnings ratio (PE ratio) of -2.75.

KNBIF Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.080.080.0768748450.07876929CS
4-0.00076-0.9410599306590.080760.08680.0767237670.0793762CS
12-0.01-11.11111111110.090.097760.07652173950.08184977CS
26-0.01309-14.06166075840.093090.1210.07652138170.09443262CS
520.0257547.4654377880.054250.122770.044168770.08575598CS
156-0.03745-31.88590889740.117450.13290.042182020.08584558CS
260-0.021-20.79207920790.1010.18750.042155100.10696469CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
HLLPFHello Pal International Inc (CE)
US$ 0.001
(99,900.00%)
5.97k
ELYSElys BMG Group Inc (CE)
US$ 0.0004
(39,900.00%)
3.8k
MCNOMucinno Holding Inc (CE)
US$ 0.0003
(29,900.00%)
1.43k
NMRDNemaura Medical Inc (CE)
US$ 0.0002
(19,900.00%)
3.76k
BLSPBlue Sphere Corporation (CE)
US$ 0.0001
(9,900.00%)
4.67M
MCLDFmCloud Technologies Corporation (CE)
US$ 0.000001
(-99.98%)
3.93k
SLAAFSitios Latinoamerica SAB de CV (PK)
US$ 0.0002
(-99.88%)
457
UNDRUnderSea Recovery Corporation (CE)
US$ 0.000001
(-99.83%)
100k
RKOSArkose Energy Corporation (CE)
US$ 0.000001
(-99.67%)
100
QEBRVirtual Medical International Inc (CE)
US$ 0.000001
(-99.50%)
8k
HMBLHUMBL Inc (PK)
US$ 0.001
(-4.76%)
1.04B
DRNKNoHo Inc (PK)
US$ 0.0002
(0.00%)
365.28M
RDARRaadr Inc (PK)
US$ 0.0016
(6.67%)
207.89M
GRPSGold River Productions Inc (PK)
US$ 0.0003
(0.00%)
179.49M
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
163.01M

KNBIF Discussion

Ver más
teq0904 teq0904 12 meses hace
They have been making about 2,500 samples per month in their lab for distribution to doctors for more than a month. By the time the contract plant starts up at the end of March there will be over 10k samples out so lots of doctors will be familiar with the product. You can bet they went to the burn centers and other of their top identified markets first.
👍️0
teq0904 teq0904 1 año hace
Latest video on kne
https://www.facebook.com/KaneBiotechInc/videos/292568703569665
👍️0
teq0904 teq0904 1 año hace
cc on Tuesday
👍️0
teq0904 teq0904 1 año hace
Doesn't matter what you think the dog market is, because it will be sold. Strategic review nr.
👍️0
teq0904 teq0904 1 año hace
First closing of the financing is probably next week. Officers and directors are in on it.
👍️0
teq0904 teq0904 1 año hace
On the previous cc, Edwards said it is possible that the FDA will approve the manufacturing plant in time for the sales to start in Q4.
👍️0
teq0904 teq0904 1 año hace
The next quarterly cc will be late in August.
👍️0
teq0904 teq0904 1 año hace
The next step is for the outsourced manufacturing of coactiv+ to be completed. It may already be done, but it was supposed to take 3 months after receiving FDA approval.
👍️0
teq0904 teq0904 1 año hace
They have FDA approval for coactiv+.
👍️0
J_Dean J_Dean 4 años hace
This is the year. Let’s go! :)
👍️0
Golden Cross Golden Cross 5 años hace
Kane Biotech Announces Third Quarter 2019
Financial Results

https://backend.otcmarkets.com/otcapi/company/dns/news/document/40388/content
👍️0
Golden Cross Golden Cross 5 años hace
KNBIF Website:

https://www.kanebiotech.com/
👍️0
Golden Cross Golden Cross 5 años hace
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (56 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. StrixNBTM, DispersinB®, Aledex®, bluestemTM, AloSeraTM, coactiv+TM and Kane® are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE".
👍️0
Golden Cross Golden Cross 5 años hace
Monster # of filings today $KNBIF

https://www.otcmarkets.com/stock/KNBIF/disclosure
👍️0
sfld sfld 5 años hace
This might pump this week. Mentioned in a National Inflation Association newsletter today. GLTA
👍️0
pegcitygreen pegcitygreen 6 años hace
I live in Winnipeg and have personally worked with this company. Great people, great products, but the company itself always seems to struggle. Kane products are for wealthy/well off people who love their pets and more than likely do not have any kids. A very, very niche market. Their tradeshows booth is quite impressive...but that doesn't mean impressive sales.
👍️0
teq0904 teq0904 6 años hace
CEO got 2M shares in the market now.
👍️0
teq0904 teq0904 6 años hace
Jan 30 cc and presentation shows the potential markets. Just sign into it and you end up with the archive. https://edge.media-server.com/m6/p/rzpqebyy
👍️0
Macaveli Macaveli 6 años hace
Decent news released today. Plus insiders are buying. This is a hidden gem.
👍️0
teq0904 teq0904 6 años hace
Sales are slow for this startup, however the products are superb so I imagine it will be a good company in the long run. I used the oral rinse and shampoo for my dog. I don't know if the rinse is the reason, but the vet told me this month that her teeth are in excellent shape for her age.
She also had a bad itch last winter and scratched day and night. It didn't stop with the use of a vet's prescription shampoo, so I tried the Kane product with excellent results. As soon as I put it on her she stops scratching for about 1 day, so I just apply it once daily wherever I see her scratching.

I know a guy who had terrible psoriasis itching on the scalp all day and night long but it all stopped when he used the human shampoo.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock